Cannabis

Check out Grow Opportunity, a digital portal and magazine dedicated to the production of cannabis in Canada

From growing indoor or outdoor to key pitfalls in cannabis propagation, Bill MacDonald of Niagara College talks cannabis production. How similar is it to growing other horticultural crops?
Ian Davidson doesn’t mince words when talking about opportunities in the cannabis nursery game right now. “They’re profound,” says the 15-year industry vet. “There are cannabis specialists in extraction, in packaging, in marketing, you name it, but show me a single operating cannabis nursery in Canada.”
As global demand for medicinal cannabis continues to increase, PharmaCielo Ltd. is poised to become an international leader after receiving approval on February 6th and 19th in Colombia for the listing of 20 proprietary and unique tetrahydrocannabinol (THC) and cannabidiol (CBD) strains with the national cultivar registry.

The Canadian-headquartered company will now be able to produce—through its Colombian subsidiary—Colombia’s only CBD-dominant strain that meets World Health Organization (WHO) purity standards. The approval gives PharmaCielo a competitive advantage as the sole licensed producer of non-psychoactive strains in Colombia. A fully balanced THC/CBD strain was also approved, among the many others.

Federico Cock-Correa, President and CEO of PharmaCielo Colombia Holdings S.A.S., says the company can now proceed to commercial registration, production and sale of these strains within Colombia, as well as for export to global markets.

“Among those approved is an historic and unique CBD-dominant strain approved for commercial registration and sourced from the Colombian landrace strains held within our fuente semillera (a licensed seed or germplasm bank authorized by the Colombian government), the first and only one of its kind registered in Colombia,” Cock-Correa noted.

The commercial value of this 20:1 CBD primary strain is of “particular significance with the recent clarification by the WHO that medicinal CBD is not regulated under international convention,” says Dr. Delon Human, PharmaCielo’s global head of health and innovation.

“The intensity of the CBD strain profile allows us to efficiently fulfill strong global demand for pure CBD medicinal cannabis oil extracts, which we expect to dramatically increase over the next several years for this strain, as it meets both market and import requirements,” adds Dr. Human.

Since its founding, PharmaCielo has focused on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors.

In January this year, the company established a joint venture with Mino Labs to bring medicinal quality cannabis oil to Mexico. The company also went public in recent months on the Toronto Stock Venture Exchange (TSX Venture) through its Canadian parent company.
Now that recreational marijuana is legal across Canada, the need for product has increased sharply. Based on corporate statements, the 10 largest cannabis producers in the country are planning to churn out 1.8 million kilograms worth of the plant by 2020.
Dalotia coriara, is a native species of soil-dwelling rove beetles. They are light to dark brown in colour; adults are three to four millimetres long and are slender with short wing covers. An adult female lays 90 eggs in its average life span of 50 days.
As everyone in Canada is aware by now, recreational cannabis has become legal. But the full effects of legalization on the Canadian greenhouse flower and vegetable industry remains to be seen.
When the legal industry began to emerge, indoor cannabis grow facilities were considered ideal for optimal growing because of the ability to control the environment entirely. However, the industry is seeing a steady decline in cannabis prices so it’s becoming increasingly expensive to operate an indoor grow facility. As such, more and more growers are turning to greenhouse structures for their cannabis grow operation.
For horticulture, propagation using tissue culture is nothing new. In fact, the technique has been used in crops like lettuce, hops, mint, potato stock, orchids, ornamental plants and berries.
“The road from the initial idea in 2013 (of a medical marijuana operation) to where we are today … I could write a book on that,” says Edwin Jewell, president and CEO of Canada’s Island Garden (CIG) the only medical marijuana operation in Prince Edward Island.  
Vancouver, BC – Ashburton Ventures Inc. has recently announced a zeolite efficacy trial in partnership with InnoTech Alberta.
As a grower, one of your worst nightmares is finding out that you have a potential pest in your grow space. The sight of your hard work looking sickly can be very disheartening to say the least.
The talk of the town at this year’s Canadian Greenhouse Conference was, you guessed it, marijuana. Not shady back-of-hall cloakroom conversations, but openly in the show aisles, on the bus during the tours and over dinner. One of the tour stops was even to a production facility: “… Aphria, the former Leamington flower grower that transformed its flower greenhouses into a state-of-the-art regulated medical marijuana production facility.”1
Oct. 27, 2017, Smiths Falls,Ont. – Tweed Inc., a wholly-owned subsidiary of Canopy Growth Corporation, and DNA Holding LLC  have renewed and expanded their partnership through to October 2022.
Oct. 11, 2017, Smiths Falls, Ont. – British Columbia will soon be home to a 1.3-million-square-foot greenhouse cannabis operation.
Oct. 10, 2017, Vaughan, Ont. –  CannTrust Holdings Inc. has received its Health Canada cultivation licence under the ACMPR for its completed 250,000-square-foot Phase 1 redevelopment of its 430,000 square foot Niagara greenhouse facility.
Page 1 of 6

Subscription Centre

New Subscription
Already a Subscriber
Customer Service
View Digital Magazine Renew

Most Popular

Latest Events

Grower Day
Tue Jun 18, 2019
Cultivate '19
Sat Jul 13, 2019
ASHS Conference
Mon Jul 22, 2019

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.